To include your compound in the COVID-19 Resource Center, submit it here.

Aclara in microfluidics deal with Zeptosens

ACLA licensed a microfluidics patent application from Zeptosens (Witterswil, Switzerland) covering the use of microfluidic networks in which

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE